BiomeSense
Chicago
About BiomeSense
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Funding stage: Seed
- Last round: Seed (Aug 2025)
- Website: biomesense.com
- Phone: [email protected]
Industries & Categories
Analytics, Bioinformatics, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biomesense-13943 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.